The Role of Bacillus Calmette-Guérin in the Treatment of Non–Muscle-Invasive Bladder Cancer-Reference-Cited by-同舟云学术

The Role of Bacillus Calmette-Guérin in the Treatment of Non–Muscle-Invasive Bladder Cancer

Published:2010-03 Issue:3 Volume:57 Page:410-429
ISSN:0302-2838
Container-title:European Urology
language:en
Short-container-title:European Urology

Author:

Gontero Paolo,Bohle Andreas,Malmstrom Per-Uno,O’Donnell Michael A.,Oderda Marco,Sylvester Richard,Witjes Fred

Publisher

Elsevier BV

Subject

Urology

Reference92 articles.

1. Thirty years of BCG immunotherapy for non-muscle invasive bladder cancer: a success story with room for improvement;Brandau;Biomed Pharmacother,2007

2. Methodological bases for systematic reviews;Galfano;J Androl Sci,2008

3. Phillips B, Ball C, Sackett D, et al. Levels of evidence. Oxford Centre for Evidence-based Medicine Web site. http://www.cebm.net/levels_of_evidence.asp. Updated March 2009.

4. History of bacillus Calmette-Guerin and bladder cancer: an immunotherapy success story;Herr;J Urol,2008

5. Intravesical bacillus Calmette-Guerin reduces the risk of progression in patients with superficial bladder cancer: a meta-analysis of the published results of randomized clinical trials;Sylvester;J Urol,2002

Cited by 160 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Enhancing tumor-specific recognition of programmable synthetic bacterial consortium for precision therapy of colorectal cancer;npj Biofilms and Microbiomes;2024-01-20

2. Intravesical Ty21a treatment of non-muscle invasive bladder cancer induces immune responses that correlate with safety and may be associated to therapy potential;Journal for ImmunoTherapy of Cancer;2023-12

3. Bacteria-driven cancer therapy: Exploring advancements and challenges;Critical Reviews in Oncology/Hematology;2023-11

4. Therapeutic Potential of Clostridium novyi-NT in Cancer: Current Knowledge and Future Perspectives;Current Cancer Drug Targets;2023-10

5. Bacterial Peptides and Bacteriocins as Novel Treatment for Prostate Cancer;International Journal of Peptide Research and Therapeutics;2023-07-17